[SIZE=-2]New York Times[/SIZE]Health Highlights: Dec. 17, 2006
[SIZE=-1]Forbes - 59 minutes ago[/SIZE]
[SIZE=-1]Zyprexa, an anti-psychotic drug and the biggest-selling medicine for pharmaceutical company Eli Lilly, may increase the risk of getting diabetes, a possibility downplayed by company executives for more than a decade, the New York Times reports.[/SIZE]
[SIZE=-1]Drug maker accused of cover-up [SIZE=-1]Houston Chronicle[/SIZE][/SIZE]
[SIZE=-1]Eli Lilly ZYPREXA LIES! [SIZE=-1]Joplin Independent[/SIZE][/SIZE]
[SIZE=-1]New York Times - United Press International[/SIZE]
[SIZE=-1]all 36 news articles[/SIZE]
More...